SMD Rise PCL

SMD Rise PCL SGA/Revenue

The SGA to Revenue Ratio of SMD Rise PCL (SMD100.BK) as of Nov 5, 2026 is 31.80 %. In the previous year, SGA to Revenue Ratio was 30.68 % — a change of 3.64% (higher).

SGA/Revenue

31.80 %

YoY

3.64%

Last updated:

SGA to Revenue Ratio of SMD Rise PCL is 2025 31.80 % . SGA to Revenue Ratio of SMD Rise PCL was 2024 30.68 % . It decreases by 3.64% higher compared to the previous year.

The SMD Rise PCL SGA/Revenue history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

SGA/Revenue
Date
SGA/Revenue
Jan 1, 2018
11.99 THB
Jan 1, 2019
11.51 THB
Jan 1, 2020
11.18 THB
Jan 1, 2021
5.61 THB
Jan 1, 2022
4.44 THB
Jan 1, 2023
10.87 THB
Jan 1, 2024
30.68 THB
Jan 1, 2025
31.80 THB
The SMD Rise PCL SGA/Revenue history
YEARSGA/RevenueYoY
31.80 %+3.64%
30.68 %+182.40%
10.87 %+144.95%
4.44 %-20.86%
5.61 %-49.88%
11.18 %-2.82%
11.51 %-4.00%
11.99 %-12.48%
13.70 %-1.63%
13.92 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SMD Rise PCL Stock analysis

What does SMD Rise PCL do? SMD Rise PCL distributes medical devices and equipment, specializing in respiratory system products. The company imports and distributes medical equipment, supplies, and provides sleep monitoring services. It focuses on sleep disorders like obstructive sleep apnea (OSA), offering counseling and advice on CPAP devices for treatment. The firm targets patients with high blood pressure, diabetes, obesity, and various sleep issues including snoring, insomnia, and daytime sleepiness. Its subsidiary Saint Medical Trading Co.,Ltd handles additional distribution activities. The company generates revenue through the distribution of medical equipment and sleep monitoring services. It serves patients with sleep disorders and chronic conditions such as hypertension, diabetes, and obesity. The primary customers are individuals requiring respiratory support and sleep disorder management, particularly those using CPAP devices for OSA treatment. The business model emphasizes specialized medical equipment distribution and personalized patient counseling. SMD Rise PCL's product portfolio includes medical equipment for respiratory systems and sleep monitoring services. The firm provides services such as counseling on CPAP usage and advice for managing sleep disorders. It caters to specific patient segments, including those with OSA, high blood pressure, diabetes, and obesity. The subsidiary Saint Medical Trading Co.,Ltd supports the distribution network for medical supplies and equipment. SMD Rise PCL is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SMD Rise PCL stock

SGA to Revenue Ratio of SMD Rise PCL is 31.80 % in 2025.

SGA to Revenue Ratio of SMD Rise PCL changed from 30.68 % to 31.80 %, representing a 3.64% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of SGA to Revenue Ratio SMD Rise PCL since 2006 – with annual values, charts, and detailed analysis.

The SGA/Revenue ratio shows what percentage of revenue is consumed by selling, general, and administrative costs. Lower ratios indicate greater operating efficiency.

A 'good' varies by industry and company stage. On Eulerpool, you can compare SGA to Revenue Ratio's SMD Rise PCL with sector peers and the industry average to assess whether it is attractive.

To evaluate SGA to Revenue Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for SGA to Revenue Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — SMD Rise PCL

All Key Metrics — SMD Rise PCL